ArticleMetabolic brain disease2026
Increased semaphorin, neuropilin, and plexin expression plays a role in recovery after traumatic brain injury.
Article in Metabolic brain disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Semaphorins and Their Role in Neuropathic Pain.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the leading causes of death and disability globally, affecting people of all ages, is traumatic brain injury (TBI). Damage to neural tissues associated with TBI can be classified into two categories: primary damage caused by direct mechanical forces resulting from trauma and secondary damage characterized by long-term neuroinflammation resulting from the molecular response of tissues and cells following primary injury. Although the effects of semaphorin (Sema) molecules on neural repair and regeneration are known, their role in the secondary injury process after TBI remains unclear. Sema proteins bind to their receptors, members of the neuropilin and plexin protein families, to carry out their actions. In this study, after mild TBI (mTBI) was induced, an acute mTBI group (observed for 24 h), a short-term mTBI chronic group, a long-term mTBI chronic group, and a sham group were created. As a result, neuronal damage is increased in acute and chronic mTBI models. Males exhibit increased levels of Sem-3 F, Plexin-A1, Neuropilin-1, and TNF-α protein expression in the hippocampus, particularly following chronic short-term mTBI. In addition, the chronic long-term group presented greater neuropilin 1 gene expression in the hypothalamus, hippocampus, pituitary, and hypophysis. Our findings suggest that semaphorin, neuropilin, and plexin proteins may help create new treatment techniques on the basis of their potential involvement in establishing and recovering from primary and secondary damage following TBI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.